Efetividade da vacina antiamarilica 17D

Uma avaliacao epidemiologica em servicos de saude

Translated title of the contribution: Efficacy of the 17D yellow fever vaccine: An epidemiologic evaluation in health services

Henrique Leonardo Guerra, Tânia Mara Sardinha, Amélia P.A.T. Da Rosa, Maria Fernanda Lima E Costa

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The purpose of this study was to evaluate the efficacy of the 17D yellow fever vaccine in the conditions under which it is used in public health services. In 1989, a nonconcurrent prospective study was carried out in Bocaiuva, Minas Cerais State, Brazil, 6 months after mass vaccination of the population. The study population was made up of first-grade students from all the schools in Bocaiuva. The exposed group consisted of a simple random sample of vaccinated students (n = 173) and the unexposed group consisted of all those who had not been vaccinated (n = 55). Serum samples were examined with the neutralization test in mice; these tests were conducted blind, that is, the examiner did not know the vaccination status of the subject. The serology results were as follows: of those vaccinated, 75% were seropositive, 17% were seronegative, and 7% showed an inconclusive result; in the unvaccinated children, these results were 9%, 87%, and 4%, respectively. The age-adjusted seropositivity ratio between vaccinated and unvaccinated children was 7.6 (95% CI: 3.4 to 16.7). The proportion of seropositivity attributable to vaccination, adjusted for age, was 86.8% (95% CI: 70.6 to 94.0). The results showed that the efficacy of the vaccine, defined by means of seropositivity for the virus, was below the levels expected for the 17D vaccine. This may have been due to operational failures in the conservation or application of the vaccine. The results point to the need for routine systematic evaluations by the health services after mass utilization of the vaccine.

Original languagePortuguese
Pages (from-to)115-120
Number of pages6
JournalRevista Panamericana de Salud Publica/Pan American Journal of Public Health
Volume2
Issue number2
StatePublished - 1997
Externally publishedYes

Fingerprint

Yellow Fever Vaccine
Health Services Research
Vaccines
Vaccination
Students
Mass Vaccination
Neutralization Tests
United States Public Health Service
Serology
Population
Brazil
Prospective Studies
Viruses
Serum

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Efetividade da vacina antiamarilica 17D : Uma avaliacao epidemiologica em servicos de saude. / Guerra, Henrique Leonardo; Sardinha, Tânia Mara; Da Rosa, Amélia P.A.T.; Lima E Costa, Maria Fernanda.

In: Revista Panamericana de Salud Publica/Pan American Journal of Public Health, Vol. 2, No. 2, 1997, p. 115-120.

Research output: Contribution to journalArticle

Guerra, Henrique Leonardo ; Sardinha, Tânia Mara ; Da Rosa, Amélia P.A.T. ; Lima E Costa, Maria Fernanda. / Efetividade da vacina antiamarilica 17D : Uma avaliacao epidemiologica em servicos de saude. In: Revista Panamericana de Salud Publica/Pan American Journal of Public Health. 1997 ; Vol. 2, No. 2. pp. 115-120.
@article{010c9578d4ce4a7287a3cb884aca6211,
title = "Efetividade da vacina antiamarilica 17D: Uma avaliacao epidemiologica em servicos de saude",
abstract = "The purpose of this study was to evaluate the efficacy of the 17D yellow fever vaccine in the conditions under which it is used in public health services. In 1989, a nonconcurrent prospective study was carried out in Bocaiuva, Minas Cerais State, Brazil, 6 months after mass vaccination of the population. The study population was made up of first-grade students from all the schools in Bocaiuva. The exposed group consisted of a simple random sample of vaccinated students (n = 173) and the unexposed group consisted of all those who had not been vaccinated (n = 55). Serum samples were examined with the neutralization test in mice; these tests were conducted blind, that is, the examiner did not know the vaccination status of the subject. The serology results were as follows: of those vaccinated, 75{\%} were seropositive, 17{\%} were seronegative, and 7{\%} showed an inconclusive result; in the unvaccinated children, these results were 9{\%}, 87{\%}, and 4{\%}, respectively. The age-adjusted seropositivity ratio between vaccinated and unvaccinated children was 7.6 (95{\%} CI: 3.4 to 16.7). The proportion of seropositivity attributable to vaccination, adjusted for age, was 86.8{\%} (95{\%} CI: 70.6 to 94.0). The results showed that the efficacy of the vaccine, defined by means of seropositivity for the virus, was below the levels expected for the 17D vaccine. This may have been due to operational failures in the conservation or application of the vaccine. The results point to the need for routine systematic evaluations by the health services after mass utilization of the vaccine.",
author = "Guerra, {Henrique Leonardo} and Sardinha, {T{\^a}nia Mara} and {Da Rosa}, {Am{\'e}lia P.A.T.} and {Lima E Costa}, {Maria Fernanda}",
year = "1997",
language = "Portuguese",
volume = "2",
pages = "115--120",
journal = "Revista Panamericana de Salud Publica/Pan American Journal of Public Health",
issn = "1020-4989",
publisher = "Pan American Health Organization",
number = "2",

}

TY - JOUR

T1 - Efetividade da vacina antiamarilica 17D

T2 - Uma avaliacao epidemiologica em servicos de saude

AU - Guerra, Henrique Leonardo

AU - Sardinha, Tânia Mara

AU - Da Rosa, Amélia P.A.T.

AU - Lima E Costa, Maria Fernanda

PY - 1997

Y1 - 1997

N2 - The purpose of this study was to evaluate the efficacy of the 17D yellow fever vaccine in the conditions under which it is used in public health services. In 1989, a nonconcurrent prospective study was carried out in Bocaiuva, Minas Cerais State, Brazil, 6 months after mass vaccination of the population. The study population was made up of first-grade students from all the schools in Bocaiuva. The exposed group consisted of a simple random sample of vaccinated students (n = 173) and the unexposed group consisted of all those who had not been vaccinated (n = 55). Serum samples were examined with the neutralization test in mice; these tests were conducted blind, that is, the examiner did not know the vaccination status of the subject. The serology results were as follows: of those vaccinated, 75% were seropositive, 17% were seronegative, and 7% showed an inconclusive result; in the unvaccinated children, these results were 9%, 87%, and 4%, respectively. The age-adjusted seropositivity ratio between vaccinated and unvaccinated children was 7.6 (95% CI: 3.4 to 16.7). The proportion of seropositivity attributable to vaccination, adjusted for age, was 86.8% (95% CI: 70.6 to 94.0). The results showed that the efficacy of the vaccine, defined by means of seropositivity for the virus, was below the levels expected for the 17D vaccine. This may have been due to operational failures in the conservation or application of the vaccine. The results point to the need for routine systematic evaluations by the health services after mass utilization of the vaccine.

AB - The purpose of this study was to evaluate the efficacy of the 17D yellow fever vaccine in the conditions under which it is used in public health services. In 1989, a nonconcurrent prospective study was carried out in Bocaiuva, Minas Cerais State, Brazil, 6 months after mass vaccination of the population. The study population was made up of first-grade students from all the schools in Bocaiuva. The exposed group consisted of a simple random sample of vaccinated students (n = 173) and the unexposed group consisted of all those who had not been vaccinated (n = 55). Serum samples were examined with the neutralization test in mice; these tests were conducted blind, that is, the examiner did not know the vaccination status of the subject. The serology results were as follows: of those vaccinated, 75% were seropositive, 17% were seronegative, and 7% showed an inconclusive result; in the unvaccinated children, these results were 9%, 87%, and 4%, respectively. The age-adjusted seropositivity ratio between vaccinated and unvaccinated children was 7.6 (95% CI: 3.4 to 16.7). The proportion of seropositivity attributable to vaccination, adjusted for age, was 86.8% (95% CI: 70.6 to 94.0). The results showed that the efficacy of the vaccine, defined by means of seropositivity for the virus, was below the levels expected for the 17D vaccine. This may have been due to operational failures in the conservation or application of the vaccine. The results point to the need for routine systematic evaluations by the health services after mass utilization of the vaccine.

UR - http://www.scopus.com/inward/record.url?scp=0031204909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031204909&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 115

EP - 120

JO - Revista Panamericana de Salud Publica/Pan American Journal of Public Health

JF - Revista Panamericana de Salud Publica/Pan American Journal of Public Health

SN - 1020-4989

IS - 2

ER -